vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and AMERICAN SUPERCONDUCTOR CORP (AMSC). Click either name above to swap in a different company.
AMERICAN SUPERCONDUCTOR CORP is the larger business by last-quarter revenue ($74.5M vs $44.9M, roughly 1.7× AbCellera Biologics Inc.). AMERICAN SUPERCONDUCTOR CORP runs the higher net margin — 158.1% vs -19.9%, a 178.0% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 21.4%). AMERICAN SUPERCONDUCTOR CORP produced more free cash flow last quarter ($2.4M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 33.2%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Anglo American plc is a British multinational mining company with headquarters in London, England. It is the world's largest producer of platinum, representing approximately 40 percent of global output, as well as being a major producer of diamonds, copper, nickel, iron ore, polyhalite and steelmaking coal. The company has operations in Africa, Asia, Australia, Europe, North America and South America.
ABCL vs AMSC — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $74.5M |
| Net Profit | $-8.9M | $117.8M |
| Gross Margin | — | 30.7% |
| Operating Margin | -63.7% | 4.5% |
| Net Margin | -19.9% | 158.1% |
| Revenue YoY | 788.4% | 21.4% |
| Net Profit YoY | 73.9% | 4679.1% |
| EPS (diluted) | $-0.03 | $2.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $74.5M | ||
| Q3 25 | $9.0M | $65.9M | ||
| Q2 25 | $17.1M | $72.4M | ||
| Q1 25 | $4.2M | $66.7M | ||
| Q4 24 | $5.0M | $61.4M | ||
| Q3 24 | $6.5M | $54.5M | ||
| Q2 24 | $7.3M | $40.3M | ||
| Q1 24 | $10.0M | $42.0M |
| Q4 25 | $-8.9M | $117.8M | ||
| Q3 25 | $-57.1M | $4.8M | ||
| Q2 25 | $-34.7M | $6.7M | ||
| Q1 25 | $-45.6M | $1.2M | ||
| Q4 24 | — | $2.5M | ||
| Q3 24 | $-51.1M | $4.9M | ||
| Q2 24 | $-36.9M | $-2.5M | ||
| Q1 24 | $-40.6M | $-1.6M |
| Q4 25 | — | 30.7% | ||
| Q3 25 | — | 31.0% | ||
| Q2 25 | — | 33.8% | ||
| Q1 25 | — | 26.5% | ||
| Q4 24 | — | 26.6% | ||
| Q3 24 | — | 28.7% | ||
| Q2 24 | — | 30.3% | ||
| Q1 24 | — | 24.8% |
| Q4 25 | -63.7% | 4.5% | ||
| Q3 25 | -851.8% | 4.5% | ||
| Q2 25 | -290.2% | 7.8% | ||
| Q1 25 | -1479.6% | 2.5% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | -1439.4% | -1.4% | ||
| Q2 24 | -1276.2% | -8.2% | ||
| Q1 24 | -551.5% | -5.3% |
| Q4 25 | -19.9% | 158.1% | ||
| Q3 25 | -637.8% | 7.2% | ||
| Q2 25 | -203.3% | 9.3% | ||
| Q1 25 | -1077.2% | 1.8% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | -785.4% | 9.0% | ||
| Q2 24 | -504.3% | -6.3% | ||
| Q1 24 | -408.0% | -3.8% |
| Q4 25 | $-0.03 | $2.62 | ||
| Q3 25 | $-0.19 | $0.11 | ||
| Q2 25 | $-0.12 | $0.17 | ||
| Q1 25 | $-0.15 | $0.04 | ||
| Q4 24 | — | $0.06 | ||
| Q3 24 | $-0.17 | $0.13 | ||
| Q2 24 | $-0.13 | $-0.07 | ||
| Q1 24 | $-0.14 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $141.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $536.8M |
| Total Assets | $1.4B | $719.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $141.1M | ||
| Q3 25 | $83.2M | $212.9M | ||
| Q2 25 | $92.4M | $207.9M | ||
| Q1 25 | $159.3M | $79.5M | ||
| Q4 24 | $156.3M | $75.2M | ||
| Q3 24 | $126.6M | $72.1M | ||
| Q2 24 | $148.3M | $93.5M | ||
| Q1 24 | $123.6M | $90.5M |
| Q4 25 | $966.9M | $536.8M | ||
| Q3 25 | $964.0M | $342.2M | ||
| Q2 25 | $1.0B | $333.1M | ||
| Q1 25 | $1.0B | $197.1M | ||
| Q4 24 | $1.1B | $192.7M | ||
| Q3 24 | $1.1B | $187.0M | ||
| Q2 24 | $1.1B | $143.3M | ||
| Q1 24 | $1.1B | $144.6M |
| Q4 25 | $1.4B | $719.5M | ||
| Q3 25 | $1.4B | $445.6M | ||
| Q2 25 | $1.4B | $452.8M | ||
| Q1 25 | $1.3B | $310.5M | ||
| Q4 24 | $1.4B | $310.3M | ||
| Q3 24 | $1.4B | $298.4M | ||
| Q2 24 | $1.4B | $240.1M | ||
| Q1 24 | $1.5B | $232.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $3.2M |
| Free Cash FlowOCF − Capex | $-44.6M | $2.4M |
| FCF MarginFCF / Revenue | -99.4% | 3.2% |
| Capex IntensityCapex / Revenue | 21.9% | 1.2% |
| Cash ConversionOCF / Net Profit | — | 0.03× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $16.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $3.2M | ||
| Q3 25 | $-52.6M | $6.5M | ||
| Q2 25 | $-32.4M | $4.1M | ||
| Q1 25 | $-11.6M | $6.3M | ||
| Q4 24 | $-108.6M | $5.9M | ||
| Q3 24 | $-28.9M | $12.7M | ||
| Q2 24 | $-30.0M | $3.4M | ||
| Q1 24 | $-41.7M | $2.2M |
| Q4 25 | $-44.6M | $2.4M | ||
| Q3 25 | $-61.5M | $5.1M | ||
| Q2 25 | $-45.8M | $3.3M | ||
| Q1 25 | $-22.2M | $5.3M | ||
| Q4 24 | $-187.0M | $5.3M | ||
| Q3 24 | $-47.4M | $12.1M | ||
| Q2 24 | $-50.1M | $3.1M | ||
| Q1 24 | $-65.8M | $1.9M |
| Q4 25 | -99.4% | 3.2% | ||
| Q3 25 | -687.0% | 7.7% | ||
| Q2 25 | -267.9% | 4.6% | ||
| Q1 25 | -524.0% | 7.9% | ||
| Q4 24 | -3702.8% | 8.7% | ||
| Q3 24 | -728.4% | 22.3% | ||
| Q2 24 | -683.8% | 7.8% | ||
| Q1 24 | -661.5% | 4.6% |
| Q4 25 | 21.9% | 1.2% | ||
| Q3 25 | 99.7% | 2.1% | ||
| Q2 25 | 78.2% | 1.1% | ||
| Q1 25 | 251.1% | 1.6% | ||
| Q4 24 | 1552.7% | 0.9% | ||
| Q3 24 | 284.6% | 1.1% | ||
| Q2 24 | 274.6% | 0.7% | ||
| Q1 24 | 242.5% | 0.7% |
| Q4 25 | — | 0.03× | ||
| Q3 25 | — | 1.37× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 5.22× | ||
| Q4 24 | — | 2.38× | ||
| Q3 24 | — | 2.60× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
AMSC
| Equipment And Systems | $56.0M | 75% |
| Megatran | $14.1M | 19% |
| Comtrafo Industria De Transformadores Eletricos SA | $4.6M | 6% |
